{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:41:23Z","timestamp":1777606883226,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":4761,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.7861\/clinmedicine.11-2-179","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T18:27:28Z","timestamp":1361298448000},"page":"179-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible?"],"prefix":"10.1016","volume":"11","author":[{"given":"Jonathan","family":"Fallowfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.11-2-179_bib1","unstructured":"1 The National Plan for Liver Services UK. A time to act: improving liver health and outcomes in liver disease. British Association for the Study of the Liver (BASL) and British Society of Gastroenterology (BSG) (Liver Section), 2009. www.bsg.org.uk\/sections\/liver-news\/the-national-plan-for-liver-services-uk-2009.html,"},{"key":"10.7861\/clinmedicine.11-2-179_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"10.7861\/clinmedicine.11-2-179_bib3","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.11-2-179_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J Clin Invest"},{"key":"10.7861\/clinmedicine.11-2-179_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2004.03.007","article-title":"Cirrhosis reversal: a duel between dogma and myth","volume":"40","author":"Desmet","year":"2004","journal-title":"J Hepatol"},{"key":"10.7861\/clinmedicine.11-2-179_bib6","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.11-2-179_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J Clin Invest"},{"key":"10.7861\/clinmedicine.11-2-179_bib8","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","article-title":"Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis","volume":"178","author":"Fallowfield","year":"2007","journal-title":"J Immunol"},{"key":"10.7861\/clinmedicine.11-2-179_bib9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.7861\/clinmedicine.11-2-179_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2005.07.036","article-title":"Histological-hemodynamic correlation in cirrhosis \u2013 a histological classification of the severity of cirrhosis","volume":"44","author":"Nagula","year":"2006","journal-title":"J Hepatol"},{"key":"10.7861\/clinmedicine.11-2-179_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C","volume":"34","author":"Poynard","year":"2001","journal-title":"J Hepatol"},{"key":"10.7861\/clinmedicine.11-2-179_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-1536-2-6","article-title":"Role of host genetics in fibrosis","volume":"2","author":"Hold","year":"2009","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.7861\/clinmedicine.11-2-179_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"Fern\u00e1ndez","year":"2009","journal-title":"J Hepatol"},{"key":"10.7861\/clinmedicine.11-2-179_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrgastro.2009.197","article-title":"Antifibrotic therapies \u2013 emerging biomarkers as treatment end points","volume":"7","author":"Talwalkar","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.11-2-179_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.11-2-179_bib16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/00042737-200012100-00009","article-title":"Serum hyaluronan \u2013 a non-invasive test for diagnosing liver cirrhosis","volume":"12","author":"Plevris","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.11-2-179_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.21984","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers","volume":"47","author":"Guha","year":"2008","journal-title":"Hepatology"},{"key":"10.7861\/clinmedicine.11-2-179_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.2009.04062.x","article-title":"Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C","volume":"30","author":"Smith","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.11-2-179_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cld.2006.08.022","article-title":"Reversal of fibrosis: no longer a pipe dream?","volume":"10","author":"Fallowfield","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.7861\/clinmedicine.11-2-179_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cld.2008.07.011","article-title":"Current and future anti-fibrotic therapies for chronic liver disease","volume":"12","author":"Rockey","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.7861\/clinmedicine.11-2-179_bib21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/MEG.0b013e32833cca96","article-title":"Coffee and the liver: a potential treatment for liver disease?","volume":"22","author":"Masterton","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824053752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824053752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.11-2-179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:42:49Z","timestamp":1761460969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824053752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1470211824053752"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.11-2-179","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible?","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.11-2-179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2011. All rights reserved.","name":"copyright","label":"Copyright"}]}}